C
C. Daniel Mullins
Researcher at University of Maryland, Baltimore
Publications - 353
Citations - 9758
C. Daniel Mullins is an academic researcher from University of Maryland, Baltimore. The author has contributed to research in topics: Health care & Medicine. The author has an hindex of 41, co-authored 305 publications receiving 7590 citations. Previous affiliations of C. Daniel Mullins include University of Maryland, College Park & University of North Carolina at Chapel Hill.
Papers
More filters
Journal ArticleDOI
Using real-world data for coverage and payment decisions: the ISPOR Real-World Data Task Force report.
TL;DR: It is critical that policymakers recognize the benefits, limitations, and methodological challenges in using RW data, and the need to consider carefully the costs and benefits of different forms of data collection in different situations.
Journal ArticleDOI
Principles of Good Practice for Budget Impact Analysis: Report of the ISPOR Task Force on Good Research Practices—Budget Impact Analysis
Josephine Mauskopf,Sean D. Sullivan,Lieven Annemans,J. Jaime Caro,C. Daniel Mullins,Mark Nuijten,Ewa Orlewska,John B. Watkins,Paul Trueman +8 more
TL;DR: In this article, the authors present a framework for creating budget impact models, guidance about the acquisition and use of data to make budget projections and a common reporting format that will promote standardization and transparency.
Journal ArticleDOI
Concordance between administrative claims and registry data for identifying metastasis to the bone: an exploratory analysis in prostate cancer
Eberechukwu Onukwugha,Candice Yong,Arif Hussain,Arif Hussain,Brian S. Seal,C. Daniel Mullins +5 more
TL;DR: Claims-based measures using BM ICD 9 coding may be insufficient to identify patients with incident BM diagnosis and should be validated against chart data to maximize their potential for population-based analyses.
Journal ArticleDOI
Recommendations for Incorporating Patient-Reported Outcomes Into Clinical Comparative Effectiveness Research in Adult Oncology
Ethan Basch,Amy P. Abernethy,C. Daniel Mullins,Bryce B. Reeve,Mary Lou Smith,Stephen Joel Coons,Jeff A. Sloan,Keith Wenzel,Cynthia Chauhan,Wayland Eppard,Elizabeth S. Frank,Joseph Lipscomb,Stephen A. Raymond,Merianne Spencer,Sean Tunis +14 more
TL;DR: Adherence to methodologic standards for the selection, implementation, and analysis/reporting of PRO measures will lead to an understanding of the patient experience that informs better decisions by patients, providers, regulators, and payers.
Journal ArticleDOI
Good practices for real-world data studies of treatment and/or comparative effectiveness: Recommendations from the joint ISPOR-ISPE Special Task Force on real-world evidence in health care decision making
Marc L. Berger,Harold C. Sox,Richard J. Willke,Diana L. Brixner,Hans Georg Eichler,Wim G. Goettsch,David Madigan,Amr Makady,Sebastian Schneeweiss,Rosanna Tarricone,Shirley V. Wang,John B. Watkins,C. Daniel Mullins +12 more
TL;DR: Real‐world evidence (RWE) includes data from retrospective or prospective observational studies and observational registries and provides insights beyond those addressed by randomized controlled trials.